The hydrazide 5, that was obtained from 1-(4-fluorophenyl)piperazine (1), was converted to the corresponding carbothioamides 6a-c by the reaction with alkyl(aryl) isothiocyanates. The synthesis of conazole analogs 10a-f was performed via the intermediary of triazoles 7a-c. The condensation of triazoles 7a-c with several heterocyclic amines in the presence of formaldehyde afforded the corresponding N-aminoalkylated triazoles 11-14. The effect of different catalysts and solvents on conventional and microwave (MW)-prompted reactions was examined. The synthesized compounds were screened for their antimicrobial activities.
Introduction
During the past few years, the excessive use of common antimicrobial drugs has caused the emergence of resistant bacteria leading to diminished efficiency of these drugs [1] [2] [3] [4] [5] . This rapid emergence of drug resistance has now become a serious public health problem [6, 7] . The increasing resistance problem has prompted the synthesis of new chemical entities in an effort to come up with new drugs with better therapeutic properties including better tolerability, less side effects and low tendency to resistance [8] .
In recent years, the concept of hybrid molecules which contain two or more pharmacophore groups bound together covalently in one molecular framework has been introduced. It has been suggested that such compounds may inhibit two or more conventional targets simultaneously. This multiple target strategy has already resulted in the development of a number of bioactive hybrid molecules [9] .
Multicomponent reactions with at least three components in the one-pot process to give a single product represent a unique strategy leading to the formation of various bioactive molecules, due to their convergence, low energy consumption, minimum waste production, facile execution, high selectivity and productivity [10] [11] [12] . On the other hand, microwave (MW) techniques are more dynamic and effective than the conventional methods [13] [14] [15] [16] . The success of combinatorial chemistry aiming at the discovery of new drug candidates depends on the advances in the one-pot multicomponent reactions with ecofriendly procedures. Solvent is one of the key factors when it is used in large quantities [11] . Most organic solvents are toxic, and they should be used in minimum quantities as far as possible or should be replaced with nontoxic alternatives, preferably with water [17] [18] [19] [20] [21] [22] [23] .
A piperazine ring is a core structure of many marketed drugs including fluoroquinolone antibiotics such as norfloxacin, ciprofloxacin and levofloxacin [24] [25] [26] [27] [28] [29] . Substituted piperazines often show increased antimicrobial activity probably by enhancing lipophilicity of the molecule [30] . In biologically active products, piperazine is often present as a fused or oxidized form [31] or is substituted with an azole (1,2,4-triazole and/or imidazole) [32] .
Results and discussion

Chemistry
Synthesis of the target compounds was carried out as illustrated in Schemes 1 and 2. The key substrate 5 was prepared from 1-(4-fluorophenyl)piperazine (1) by conventional and also MW-assisted methods in four steps.
The treatment of 5 with phenyl, benzyl or ethyl isothiocyanate generated the corresponding carbothioamide derivatives 6a-c. The reactions were conducted in dichloromethane at room temperature and under MW irradiation in the attempts to maximize the yields of the products and minimize the reaction times. The reaction time for complete consumption of starting materials was lowered from 24 h for a conventional heating to a remarkable 8 min using MW irradiation. The optimal MW power in terms of yield and product stability was assessed at 150 W at 125°C in a closed vessel without any solvent. Products 6a-c were obtained in yields of 91%-97%.
The treatment of compounds 6a-c with a base yielded 1,2,4-triazole derivatives 7a-c. The ring closure reactions leading to compounds 7a-c were identified with IR, 1 H NMR, 13 C NMR, mass spectral and elemental analyses. Our previous studies [5, 24, 30, [33] [34] [35] have demonstrated that the 3-mercapto-1,2,4-triazoles can exist in a thione or thiol tautomeric form and this conclusion is also true for compounds 7a-c. On the basis of analysis of the spectral data (see Experimental section), it can be suggested that 7a,b and 7c exist preferentially in the respective thione and thiol forms.
Alkylation of compounds 7a-c with 2-bromo-1-(4-chlorophenyl)ethanone in ethanol afforded the corresponding compounds 8a-c. Compared with a conventional heating, MW irradiation decreased the reaction time from 22 h to 25 min and increased the yields from 22%-35% to 52%-75%. The best yields were obtained at 150°C for 25 min at 150 W maximum power. Compounds 7a-c can, in principle, be alkylated at the sulfur or nitrogen atom. The structures of the resultant products 8a-c were suggested (see Experimental) based on the spectral data but additional work is needed to support this analysis. The reduction of carbonyl group with NaBH 4 in 8a-c to alcohol gave compounds 9a-c which, again, was achieved using both classical heating and MW irradiation. For MW-prompted reactions leading to the formation of compounds 9a-c, the reduction of compound 9a was selected as model and the effects of various reaction parameters, including solvent, temperature, time and MW power were examined. The results showed that the best yield was obtained in ethanol with MW irradiation at 100 W and 100°C for 20 min. The synthesis of compounds 10a-f was achieved by treatment of compounds 9a-c with substituted benzyl chlorides, namely 4-chloro-, 2,4-dichloro-and 2,6-dichlorobenzyl chlorides in the presence of NaH under MW-mediated and conventional conditions. In order to improve the MW conditions, the reaction leading to the formation of 10a was selected as a model reaction and the effects of several parameters including time, power and solvent were examined. After optimization of the conditions for the preparation of 10a, the synthesis of the remaining compounds 10b-i was carried out. Again, it should be noted that the structural assignments for products 9a-c and 10a-i are tentative and additional work is needed to show the N-or S-alkylation site (Scheme 1). The aminoalkylation of compounds 7a-c with several secondary amines, namely norfloxacin (for 11a-c), ciprofloxacin (for 12a-c), thiomorpholine (for 13a,b) and phenylpiperazine (for 14) in the presence of formaldehyde was conducted under the MW-assisted Mannich reaction conditions (Scheme 2). Initially, to optimize the conditions for this one-pot three-component reaction, compound 11a was selected as a model product, and the model reactions were performed in polar solvents and without solvent in the presence of different Lewis and Bronsted acid catalysts such as p-TSA, FeCl 3 , InCl 3 and HCl. The effects of various reaction parameters, including temperature, catalyst, solvent, MW power and time were examined. In all cases, completion of the reaction was monitored by the thin-layer chromatography (TLC) analysis. The solvent-free reaction with HCl as a catalyst constituted the optimal method yielding the desired product 11a within 20 min at 70 W with the yield of 83%. The spectral analysis of products 11-14 (see Experimental section) strongly suggested the N-alkylated thione structure in all cases as shown in Scheme 2.
Mannich bases have been used previously as potentially useful prodrug candidates for imides, amides, amines, hydantoin and urea derivatives. It is believed that the N-alkyl group in Mannich bases increases the lipophilicity of the parent amines at physiological pH values by decreasing their protonation that results in enhancement of absorption through biomembranes [33] .
Biological activity
All compounds were tested for their antimicrobial activities, and the results for active derivatives are presented in Table 1 . Compounds of low activity are not included. No clear structure-activity relationships can be detected, indicating that the antibacterial activity is significantly affected by the nature of the compound. It is evident from Table 1 that the aminoalkylation of triazoles 7a-c with fluoroquinolones namely norfloxacin and ciprofloxacin gives rise to the excellent activity of the resultant products 11a-c and 12a-c toward the test bacteria with the minimum inhibitory concentration (MIC) values between 0.24 and 1.9 μg/mL. It can be suggested that excellent activity of these compounds is due to the presence of a fluoroquinolone core in their structures. In fact, the MIC values of compounds 11a-c are similar to the MIC values of norfloxacine and ciprofloxacine. Among the aminoalkylated triazoles, especially the ones containing an aromatic substituent at the position 4 of a 1,2,4-triazole ring, compounds 11a,b and 12a,b are the most active. Compounds 2-9 except 8b and 10a did not exhibit noteworthy activity toward the test microorganisms.
Experimental Chemistry
The chemicals were purchased from Fluka Chemie AG (Buchs, Switzerland) and used without purification. Melting points were determined in open capillaries on a Büchi B-540 melting point apparatus and are uncorrected. Reactions were monitored by TLC on silica gel 60 F254 aluminum sheets. The mobile phase was ethyl acetate/ diethyl ether (1 : 1) and detection was made using UV light. Fourier transform infrared (FT-IR) spectra were recorded using a Perkin Elmer 1600 series spectrometer.
1 H NMR and 13 C NMR spectra were registered in DMSO-d 6 on a Bruker Avene II 400 NMR spectrometer (400 MHz for 1 H and 100 MHz for 13 C). The elemental analysis was performed on a Costech Elemental Combustion System CHNS-O elemental analyzer. The electron ionization (EI) mass spectra were obtained on a Quattro GC-MS (70 eV) instrument. MW-assisted reactions were performed in a CEM Discovery reactor.
1-(2-Fluoro-4-nitrophenyl)-4-(4-fluorophenyl)-piperazine (2)
Method 1 A mixture of 1-(4-fluorophenyl)-piperazine (10 mmol), 3,4-difluoronitrobenzene (10 mmol) and NaHCO 3 (30 mmol) in acetonitrile (50 mL) was heated under reflux for 8 h. Concentration under reduced pressure resulted in the formation of a yellow solid that was treated with water, filtered off and crystallized from ethyl acetate to give the target yellow compound in a 64% yield. 
3-Fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]aniline (3)
Method 1 Pd/C catalyst (5 mmol) and hydrazine hydrate (50 mmol) were added to the solution of compound 2 (10 mmol) in 1-butanol (50 mL) and the mixture was heated under reflux for 15 h and then the catalyst was removed by filtrating the hot mixture on celite. Concentration under reduced pressure resulted in the formation of an oily mass that was crystallized from ethanol to give the target white compound in a 53% yield.
Method 2 Pd/C (5 mmol) catalyst and hydrazine hydrate (5 mmol) were added to the solution of compound 2 (10 mmol) in 1-butanol and the mixture was irradiated in a MW reactor with pressure control at 150°C, 200 W for 50 min. Then, the catalyst was separated by filtration and the solvent was evaporated under reduced pressure. 
Ethyl 2-{3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl] phenyl}amino)acetate (4)
Method 1 A mixture of compound 3 (10 mmol) and triethylamine (15 mmol) in dry tetrahydrofuran (50 mL) was treated dropwise at 0-5°C with ethyl bromoacetate (10 mmol). Then, the mixture was allowed to reach room temperature and was stirred for an additional 24 h. The precipitated triethylammonium salt was removed by filtration. Concentration under reduced pressure resulted in the formation of a brown solid that was crystallized from ethanol/water (1 : 3) to give the target compound in a 47% yield.
Method 2 Triethylamine (1.5 mmol) was added dropwise at 0-5°C to the mixture of compound 3 (1 mmol) and ethyl bromoacetate (1 mmol). Then, the mixture was irradiated in a MW reactor with pressure control at 70°C, 70 W for 8 min. Water was added and the resultant solid was filtered off and crystallized from ethanol/water (1 : 3) to give the target brown compound in a 88% yield; mp 131-132°C; IR: 
2-{3-Fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]-phenylamino}acetohydrazide (5)
Method 1 Hydrazine hydrate (25 mmol) was added to a solution of compound 4 (10 mmol) in ethanol and the mixture was heated under reflux for 10 h. Concentration under reduced pressure resulted in the formation of a white solid that was crystallized from ethyl acetate to give the target compound in a 72% yield.
Method 2 A mixture of hydrazine hydrate (2.5 mmol) and compound 4 (1 mmol) was irradiated in a MW reactor with pressure control at 150°C, 125 W for 30 min. The product was crystallized from ethyl acetate to give white compound in a 95% yield; mp 146-148°C; IR: ν max 3500 and 3406 (NH 2 ), 3304 (2NH), 1631 cm − 1 (C=O); 
General method for synthesis of compounds 6a-c
Method 1 Alkyl(aryl) isothiocyanate (10 mmol) was added to a solution of compound 5 (10 mmol) in dichloromethane and the mixture was stirred at room temperature for 24 h. The resultant solid was collected by filtration and crystallized from acetone/diethyl ether (1 : 2).
Method 2 A mixture of compound 5 (1 mmol) and alkyl(aryl) isothiocyanate (1 mmol) was irradiated in a MW reactor with pressure control at 125°C, 150 W for 8 min without any solvent. The resultant solid product was crystallized from acetone/diethyl ether (1 : 2). 
2-{2-[3-Fluoro-4-(4-[4-fluorophenyl]piperazin-1-yl)phenyl] amino)acetyl}-N-phenylhydrazinecarbothioamide (6a) Yield
General method for synthesis of compounds 7a-c
Method 1 A solution of compound 6 (10 mmol) in water was heated under reflux in the presence of 2M NaOH (50 mL) for 6 h, then cooled to room temperature and acidified to pH 4 with 37% HCl. The resultant precipitate was filtered off, washed with water and crystallized from dimethyl sulfoxide/water (1 : 4).
Method 2 A solution of 6 (1 mmol) in 2N NaOH (5 mL) was irradiated in a MW reactor with pressure control at 150°C, 200 W for 15 min, then cooled to room temperature and acidified to pH 4 with 37% HCl. The resultant precipitate was filtered off, washed with water and crystallized from dimethyl sulfoxide/water (1 : 4). 4H-1,2,4-triazole-3-thiol (7c) 
5-[({3-Fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl} amino)methyl]-4-phenyl-2,4-dihydro-
= 230 Hz)], 168.3 (triazole C-3), 181.4 (triazole C-5)
4-Ethyl-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-
General method for synthesis of compounds 8a-c
Method 1 A solution of compound 7 (10 mmol) and sodium ethoxide prepared from metallic sodium (10 mmol) and ethanol was heated under reflux for 2 h. Then, 2-bromo-1-(4-chlorophenyl)ethanone (10 mmol) was added and the mixture was heated under reflux for an additional 20 h and then concentrated and the residue was treated with water. The resultant solid was crystallized from acetone to give an orange product. Benzyl-3-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl] 
4-
)
1-(4-Chlorophenyl)-2-({4-ethyl-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-4H-1,2,4-triazol-3-yl} thio)ethanone (8c) Yield
General method for synthesis of compounds 9a-c
Method 1 Compound 8 (10 mmol) was stirred in the presence of NaBH 4 (30 mmol) in absolute ethanol (40 mL) at room temperature for 24 h (for 9a and 9c) or heated under reflux for 18 h (for 9b). Concentration under reduced pressure resulted in the formation of a white solid that was washed with water and crystallized from acetone.
Method 2 A solution of compound 8 (1 mmol) and NaBH 4 (3 mmol) in ethanol was irradiated at 100°C, 100 W for 20 min. Concentration under reduced pressure resulted in the formation of a white solid that was washed with water and crystallized from acetone. -2-[2-(4-chlorophenyl)-2-hydroxyethyl]-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (9b) 
2-[2-(4-Chlorophenyl)-2-hydroxyethyl]-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (9a) Yield
4-Benzyl
1-(4-Chlorophenyl)-2-({4-ethyl-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-4H-1,2,4-triazol-3-yl}thio)ethanol (9c) Yield
General method for synthesis of compounds 10a-i
Method 1 NaH (10 mmol) was added to a solution of compound 9 (10 mmol) in tetrahydrofuran and the mixture was heated under reflux for 6 h. Then, the corresponding benzyl chloride was added and the mixture was heated under reflux for an additional 8-12 h. After concentration under reduced pressure, the resultant oily mass was treated with K 2 CO 3 (10 mmol) solution and the mixture was extracted with ethyl acetate (3 × 15 mL). The organic layer was dried with Na 2 SO 4 and concentrated under reduced pressure. The residue was crystallized from acetone (10a-d, 10g) or purified by silica gel column chromatography eluting with ethyl acetate/n-hexane (3 : 7, 10e, 10f, 10h, 10i).
Method 2 NaH (1 mmol) was added to a solution of compound 9 (1 mmol) in THF (10 mL) and the mixture was irradiated at 80°C, 100 W for 10 min. Then, the corresponding benzyl chloride (3 mmol) was added, and heating was continued for 20 min at 100°C at 150 W. After concentration the crude product was treated with K 2 CO 3 (10 mmol) solution and the mixture was extracted with ethyl acetate (3 × 15 mL). The extract was dried with Na 2 SO 4, concentrated under a reduced pressure and the residue was crystallized from acetone (10a-d, 10g) or purified by silica gel column chromatography eluting with ethyl acetate/n-hexane, (3 : 7, 10e, 10f, 10h, 10i ). Chlorophenoxy)-2-(4-chlorophenyl)ethyl]-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3 -2-[2-[(4-chlorobenzyl)oxy]-2-(4-chlorophenyl)  ethyl]-5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-2,4-dihydro-3H-1,2,4-triazole-3 4-dihydro-3H-1,2,4-triazole-3-thione (10f N-[(5-{[2-(4-Chlorophenoxy)-2-(4-chlorophenyl)ethyl]thio}-4-ethyl-4H-1,2,4-triazol-3-yl)methyl]-3-fluoro-4-[4-(4-fluorophenyl) 
2-[2-(4-
4-Benzyl
General method for synthesis of compounds 11-14
Method 1 To a solution of corresponding compound 7 (10 mmol) in DMF containing HCl (50% mmol), norfloxacin (for 11a-c), ciprofloxacin (for 12a-c), thiomorpholine (for 13a,b) or phenylpiperazine (for 14) (10 mmol) was added and the mixture was stirred at room temperature in the presence of formaldehyde (50 mmol) for 24 h. The solid obtained was collected by filtration, washed with water and crystallized from DMSO/water (1 : 3). solution of 7 (1 mmol), norfloxacin (for 11a-c), ciprofloxacin (for 12a-c), thiomorpholine (for 13a,b) or phenylpiperazine (for 14) (1 mmol), HCl (50% mmol) and formaldehyde (5 mmol) was irradiated in a MW reactor with pressure control at 50°C, 70 W for 20 min. The resultant solid was washed with water and crystallized from DMSO/water (1 : 3). Ethyl-7-[4-({4-ethyl-3-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}methyl)piperazin-1-yl]-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (11c -5-[({3-fluoro-4-[4-(4-fluorophenyl)piperazin-1-yl]phenyl}amino)methyl]-2-(thiomorpholin-4-ylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione (13b 
Method 2 A
1-Ethyl
1-
4-Ethyl
Antimicrobial activity assessment
The test microorganisms were obtained from the Hifzissihha Institute of Refik Saydam (Ankara, Turkey) and were as follows: E. coli ATCC35218, Y. pseudotuberculosis ATCC911, P. aeruginosa ATCC43288, E. faecalis ATCC29212, S. aureus ATCC25923, B. cereus 709 Roma, M. smegmatis ATCC607, C. albicans ATCC60193 and S. cerevisia RSKK 251. All compounds were weighed and dissolved in dimethyl sulfoxide to prepare a stock solution of 20.0 μg/mL. The antimicrobial effects of the compounds were tested quantitatively in respective broth media by using double microdilution and the MIC values (μg/mL) were determined. The antibacterial and antifungal assays were performed in Mueller-Hinton broth (MH) (Difco, Detroit, MI, USA) at pH 7.3 and buffered Yeast Nitrogen Base (Difco, Detroit, MI, USA) at pH 7.0, respectively. The microdilution test plates were incubated for 18-24 h at 35°C. Brain Heart Infusion broth (BHI) (Difco, Detriot, MI, USA) was used for M. smegmatis and incubated for 48-72 h at 35°C [36] . Ampicillin (10 μg) and fluconazole (5 μg) were used as the standard antibacterial and antifungal drugs, respectively. DMSO with a dilution of 1 : 10 was used as a solvent control.
